Overview

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects of anti-HIV drug courses of different lengths in infants who became HIV infected at birth.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Abacavir
Didanosine
Efavirenz
Lamivudine
Lopinavir
Nevirapine
Ritonavir
Zidovudine